Cell Signaling Technology (Cst)

Cell Signaling Technology (Cst) company information, Employees & Contact Information

Founded by research scientists in 1999, Cell Signaling Technology (CST) is a private, family-owned company that prides itself on operating as a research institute developing quality products for other researchers. Active in the field of applied systems biology research, particularly as it relates to cancer, CST understands the importance of using antibodies. That's why all of our antibodies are painstakingly validated for multiple applications by our Ph.D. level scientists. And the same CST scientists who helped produce your antibody will also provide technical support, methods, and guidance needed to achieve the most reliable results. Check out our website! For Research Use Only. Not for Use in Diagnostic Procedures.

Company Details

Employees
1.85K
Founded
-
Address
3 Trask Lane, Danvers,ma 01923,united States
Phone
9788672400
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Danvers, MA
Looking for a particular Cell Signaling Technology (Cst) employee's phone or email?

Cell Signaling Technology (Cst) Questions

News

Leveragen Partners with Cell Signaling Technology to Advance Reagent Antibody Innovation with Proprietary Nanobody Technology - Business Wire

Leveragen Partners with Cell Signaling Technology to Advance Reagent Antibody Innovation with Proprietary Nanobody Technology Business Wire

Cell Signaling Technology, Inc. - Drug Target Review

Cell Signaling Technology, Inc. Drug Target Review

Akt–RSK–S6 Kinase Signaling Networks Activated by Oncogenic Receptor Tyrosine Kinases - Science | AAAS

Akt–RSK–S6 Kinase Signaling Networks Activated by Oncogenic Receptor Tyrosine Kinases Science | AAAS

Profiling of UV-induced ATM/ATR signaling pathways - PNAS

Profiling of UV-induced ATM/ATR signaling pathways PNAS

Cell Signaling Technology Leverages Integrated Cyber's Employee-Focused Cybersecurity Service - Investing News Network

Cell Signaling Technology Leverages Integrated Cyber's Employee-Focused Cybersecurity Service Investing News Network

A maladaptive feedback mechanism between the extracellular matrix and cytoskeleton contributes to hypertrophic cardiomyopathy pathophysiology | Communications Biology - Nature

A maladaptive feedback mechanism between the extracellular matrix and cytoskeleton contributes to hypertrophic cardiomyopathy pathophysiology | Communications Biology Nature

Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results - ScienceDirect.com

Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results ScienceDirect.com

AmoyDx and CST Expand Existing Partnership for the Development of Companion Diagnostics (CDx) to Support Precision Oncology - News-Medical

AmoyDx and CST Expand Existing Partnership for the Development of Companion Diagnostics (CDx) to Support Precision Oncology News-Medical

A novel small molecule RK-019 inhibits FGFR2-amplification gastric cancer cell proliferation and induces apoptosis in vitro and in vivo - Frontiers

A novel small molecule RK-019 inhibits FGFR2-amplification gastric cancer cell proliferation and induces apoptosis in vitro and in vivo Frontiers

Is the reversal of cellular aging possible through chemical means? - Longevity.Technology

Is the reversal of cellular aging possible through chemical means? Longevity.Technology

Key signaling pathways in cancer: Links to developmental biology - Science | AAAS

Key signaling pathways in cancer: Links to developmental biology Science | AAAS

'Human cell' image isn't what it seems when put under the microscope - aap.com.au

'Human cell' image isn't what it seems when put under the microscope aap.com.au

Lunaphore and CST Partnership Advances Spatial Biology Research with Over 1,700 IHC-Validated Antibodies for Use on COMET™ - Business Wire

Lunaphore and CST Partnership Advances Spatial Biology Research with Over 1,700 IHC-Validated Antibodies for Use on COMET™ Business Wire

Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity - ScienceDirect.com

Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity ScienceDirect.com

How to Achieve Better Results Using PASS-Based Virtual Screening: Case Study for Kinase Inhibitors - Frontiers

How to Achieve Better Results Using PASS-Based Virtual Screening: Case Study for Kinase Inhibitors Frontiers

Identification of a DYRK1A Inhibitor that Induces Degradation of the Target Kinase using Co-chaperone CDC37 fused with Luciferase nanoKAZ - Nature

Identification of a DYRK1A Inhibitor that Induces Degradation of the Target Kinase using Co-chaperone CDC37 fused with Luciferase nanoKAZ Nature

Part 5: Targeting Cancer Pathways: Understanding Immune Checkpoints - Science | AAAS

Part 5: Targeting Cancer Pathways: Understanding Immune Checkpoints Science | AAAS

A precision therapy against cancers driven by KIT/PDGFRA mutations - Science | AAAS

A precision therapy against cancers driven by KIT/PDGFRA mutations Science | AAAS

Top Cell Signaling Technology (Cst) Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant